In our cohort, patients receiving targeted therapy (anti-VEGF agents) showed higher levels of 24 h proteinuria compared with those not exposed to targeted treatments, although the difference did not reach statistical significance and remained within the non-nephrotic range.
← all excerpts
Cardiovascular and Renal Risk Stratification in Patients Referred to an Onconephrology Clinic and Undergoing Different Oncology Therapies: A Real-World Study
1
—
—